Arnuity Ellipta (fluticasone furoate)
Written by: Sarah O'Brien | Last Reviewed: May 2016.
- Arnuity Ellipta [prescribing information]. Research Triangle Park, NC: GlaxoSmithKline; 2014.
- Arnuity Ellipta [patient information]. Research Triangle Park, NC: GlaxoSmithKline; 2014.
- Lötvall J, Bleecker ER, Busse WW, et al. Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: a 24-week placebo and active-controlled randomised trial. Respir Med. 2014;108:41-49.
- Bleecker ER, Lötvall J, O'Byrne PM, et al. Fluticasone furoate-vilanterol 100-25 mcg compared with fluticasone furoate 100 mcg in asthma: a randomized trial. J Allergy Clin Immunol Pract. 2014;2:553-61.
- Woodcock A, Lötvall J, Busse WW, et al. Efficacy and safety of fluticasone furoate 100 μg and 200 μg once daily in the treatment of moderate-severe asthma in adults and adolescents: a 24-week randomised study. BMC Pulm Med. 2014;14:113.
- O'Byrne PM, Bleecker ER, Bateman ED, et al. Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma. Eur Respir J. 2014;43:773-782.